Table 4.

Overview on observed secondary autoimmune disorders in the PROGRAM^MS cohort

Secondary autoimmune disorder	Cases	Onset from baseline infusion (months)
Graves’ disease	28	6–47 (median: 20)
Autoimmune thyroiditis	12	6–39 (median: 17.5)
Autoimmune thrombocytopenia	5	9, 11, 26, 27, 35
Vitiligo	4	17, 24, 45, 51
Autoimmune hepatitis	2	12, 19
Autoimmune neutropenia	1	25
Idiopathic Castleman’s disease	1	40

Given the high abundance, we did not indicate the time of onset from baseline in patients with thyroid autoimmunity but showed median and range. In other diseases, the numbers indicate the months of onset from baseline in the respective patients.